Yunoki Marina, Fukuchi Kensuke, Fujiyama Toshiharu, Ito Taisuke, Honda Tetsuya
Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, JPN.
Cureus. 2024 Aug 21;16(8):e67391. doi: 10.7759/cureus.67391. eCollection 2024 Aug.
A 35-year-old male patient with atopic dermatitis (AD) was referred to our department for exacerbated AD lesions. His sudden discontinuation of topical corticosteroid had induced erythroderma on his face, extremities, and trunk. Additionally, he presented small multiple whitish papules, mainly on the trunk and thighs, diagnosed as molluscum contagiosum (MC). Dupilumab was initiated in combination with a topical corticosteroid (0.05% betamethasone butyrate propionate). After four weeks, the AD symptoms substantially improved, while MC showed no changes. After 11 weeks of dupilumab therapy, he abruptly stopped topical corticosteroid treatment, and the MC lesions completely resolved in two weeks.
一名35岁的特应性皮炎(AD)男性患者因AD皮损加重被转诊至我科。他突然停用外用糖皮质激素后,面部、四肢和躯干出现了红皮病。此外,他躯干和大腿上出现了多个小的白色丘疹,诊断为传染性软疣(MC)。开始使用度普利尤单抗联合外用糖皮质激素(0.05%丙酸倍他米松丁酸酯)治疗。四周后,AD症状显著改善,而MC无变化。度普利尤单抗治疗11周后,他突然停止外用糖皮质激素治疗,MC皮损在两周内完全消退。